Clinical Trial Update: A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma

View source ↗

Summary

A prospective clinical trial compares DRd (daratumumab, lenalidomide, dexamethasone) with VRd-lite (bortezomib, lenalidomide, dexamethasone) in elderly patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Multiple Myeloma | Status: RECRUITING